Clinical characteristics
| AS (n = 24) | DCM (n = 10) | p Value | |
|---|---|---|---|
| Data are mean (SD), number, or percentage. | |||
| ACE-I, angiotensin converting enzyme inhibitor; ARB, angiotensin I receptor blocker; AS, aortic valve stenosis; BSA, body surface area; CRP, C reactive protein; DCM, dilated cardiomyopathy; NS, not significant; NYHA, New York Heart Association. | |||
| Sex (men/women) | 14/10 | 6/4 | NS |
| Age (years) | 70 (8) | 56 (12) | 0.001 |
| NYHA class | 2.2 (0.9) | 2.6 (1.1) | 0.030 |
| BSA (m2) | 1.81 (0.05) | 1.94 (0.04) | NS |
| Serum creatinine (μmol/l) | 88 (18) | 106 (35) | NS |
| Serum blood urea (mmol/l) | 8.2 (1.8) | 14 (2.1) | NS |
| Serum sodium (mmol/l) | 142 (3) | 143 (2) | NS |
| White cell count (×109/l) | 8 (2) | 8 (3) | NS |
| CRP (mg/l) | 0.5 (0.1) | 0.4 (0.2) | NS |
| Medications | |||
| ACE-I or ARB | 14% | 27% | NS |
| Diuretics | 25% | 65% | 0.002 |
| β Blockers | 36% | 24% | NS |
| Digoxin | 0% | 0% | NS |